Researchers: Viruses Like COVID-19 Can Be Prevented With the Development of a Targeted Nasal Spray Solution

 

 

As the world continues to grapple with the ongoing COVID-19 pandemic, scientists are not just working on vaccines and treatments but also on preventive measures that could be simpler yet effective. Imagine a world where a spritz of a nasal spray could help you fight the virus? That notion isn’t just wishful thinking; it’s grounded in intensive research into the anatomy of our respiratory system. Scientists have identified the ports of entry that SARS-CoV-2 exploits to initiate an infection. Once these entry points are known, it becomes possible to develop targeted interventions, specifically targeting the nose. Such a preventive measure could be revolutionary. And not only in combating COVID-19, but also in preparing us for future pandemics of respiratory viruses. 

Detailing more on this exciting frontier is Dr. Radwa Emad Ewaisha, Assistant Professor of Microbiology and Immunology at the Faculty of Pharmacy at Alexandria University

She has been teaching and conducting research there since January 2019. She earned her Ph.D. in Cellular and Molecular Biology from Arizona State University. Additionally, she also obtained a Master’s there in the same field. Dr. Ewaisha also completed a Clinical Chemistry Post-PhD Fellowship at the prestigious Mayo Clinic School of Medicine. Prior to her doctorate, she earned a Master’s degree in Pharmaceutical Sciences focusing on Pharmaceutical Microbiology from Alexandria University.

Upon conclusion of recent research exploring nose cells, she added that the development of a nasal solution as a shield against viral infections could be a preventative measure for other possible viral infections. Dr. Ewaisha also stated that this nasal cell research will be groundbreaking for the pharmaceutical industry. 

Dr. Ewaisha’s Thoughts on a Nasal Spray Solution

“These researchers studied cells that line the nose and airway, and they studied the microstructures that are found on these cells, such as cilia and microvilli. They were then able to identify the specific ports of entry in our noses that SARS-CoV-2 uses to start an infection. This means that, in theory, a prophylactic nasal spray can be developed, especially one that can be used following a suspected exposure to the virus, and this has very important implications not only for COVID, but potentially for future pandemics as well. 

“This study has identified targets in these cells that, when inhibited, this can actually prevent respiratory viruses from establishing a stronghold in our nose or throat and spreading the infection to neighboring cells. These targets provide new avenues for pharmaceutical companies to develop and market a prophylactic nasal spray that can abort the infection.”

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More